Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  PEG-interferon alfa-2a
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
PEG-Interferon Alfa-2a or Hydroxyurea in Treating Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MPD-RC 112, NCI-2012-00269, NCT01259856
PEG-interferon Alfa-2a in Treating Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MPD-RC 111, NCI-2012-00268, 111, NCT01259817
Romiplostim in Treating Hepatitis C-Infected Patients with Thrombocytopenia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NC-HEM-07-5, NCI-2010-00358, HS-08-00140, NCT01153919
Start Over